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Abstract 
 
Fiber content of the post calving diet may have implications for both the energetic and 
inflammatory status of early lactation dairy cows. The objective of my thesis was to specifically 
examine the effect of high fiber dietary intervention on hepatic metabolism, namely hepatic gene 
expression of insulin-like growth factor one (IGF-I), growth hormone receptor (GHR), tumor 
necrosis factor alpha (TNFα), and TNFα receptor (TNFRSF1a) in lactating cows, with the goal of 
minimizing NEBAL and systemic inflammation during the early postpartum period. While 
examining the effect of diet on hepatic gene expression, I also wanted to analyze the effect of 
genotype and other information collected throughout the study related to energy balance, 
metabolism, and liver health on the hepatic expression of these genes. Multiparous Holstein cows 
(n=40) were fed a common prepartum ration and assigned randomly at calving to one of two 
postpartum diets differing in fiber content; high fiber (n=19; 35.3% NDF1, 12.2% uNDF240
2, 
23.2% peNDF3) and low fiber (n=21; 32.8% NDF, 9.5% uNDF240, 21.6% peNDF). Liver 
biopsies and blood samples were obtained on d 7 and d 14 postpartum. Liver tissue was analyzed 
for mRNA expression of IGF-I, GHR, TNFα, and TNFRSF1a by RT-qPCR. Blood samples were 
used for plasma metabolic profile analysis as well as to DNA genotype each cow for IGF-I, GHR, 
and TNFα single nucleotide polymorphisms (SNPs) by PCR-restriction fragment length methods. 
Data were analyzed by repeated measures ANOVA with fixed effects of dietary treatment, 
                                                          
 
1 Neutral Detergent Fiber 
2 Undigested Neutral Detergent Fiber; remaining fiber after 240h in vitro digestion 
3 Physically effective Neutral Detergent Fiber; above 4mm screen when using Penn State Particle Separator 
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genotype for all genes, time, parity group, and all interactions. Correlations were computed 
between gene expression and 19 other variables related to production, metabolism and health. 
There were no effects of dietary treatment on hepatic gene expression of IGF-I, GHR, TNFα, or 
TNFRSF1a. Trends (P<0.15) towards differences in gene expression based on genotype were 
present, such that GHR genotype AB cows had higher IGF-I and GHR expression, and TNFα 
genotype AB cows had lower IGF-I expression. Hepatic expression of IGF-I and GHR was 
correlated positively (P<0.05) with variables related to increased energy balance and improved 
liver health. TNFα and TNFRSF1a correlated (P<0.05) positively with markers associated with 
decreased liver health.  While there was no difference in hepatic gene expression of IGF-I, GHR, 
TNFα, or TNFRSF1a between dietary treatments, genotype appears to influence hepatic gene 
expression of IGF-I and GHR.   
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Introduction  
 
The transition period, defined as 3 weeks before to 3 weeks after calving (Grummer, 1995), 
is a time of major metabolic adaptation for the dairy cow. Transitioning from late pregnancy to 
early lactation is associated with a large increase in the demands for glucose, amino acids, and 
fatty acids in order to support the energetic costs of milk production (Bell 1995). Although a cow’s 
dry matter intake (DMI) increases postpartum, it does not increase quickly enough to meet the 
demands for rising milk production, leaving her in a prolonged state of negative energy balance 
(NEBAL) in early lactation (Bell, 1995; Butler et al., 2003).  
Negative energy balance is characterized by decreased blood glucose and insulin 
concentrations with elevated blood growth hormone (GH) concentrations, and this relationship 
between blood glucose, insulin, and GH forms the basis of the GH-IGF-I axis (Butler et al., 2003). 
Under positive energy balance in times of normal insulin, GH would bind to hepatic growth 
hormone receptor (GHR). This results in the production of insulin-like growth factor (IGF-I), a 
polypeptide that provides negative feedback for GH. The ability of IGF-I to decrease circulating 
GH concentrations, as well as bind to insulin receptors, enhances insulin sensitivity (Yakar et al., 
2001). During NEBAL, the GH-IGF-I axis is uncoupled; plasma insulin levels are low, which 
lowers hepatic GHR concentrations and renders the liver resistant to circulating GH (Butler et al., 
2003) resulting in lower IGF-I production. Decreased plasma insulin concentrations (Butler et al., 
2003) and decreased insulin sensitivity due to lower IGF-I production (Yakar et al., 2001) 
promotes efficient glucose utilization by the non-insulin sensitive mammary gland as opposed to 
glucose being utilized by peripheral tissues (Bell and Bauman 1997). Lower circulating insulin 
and IGF-I with higher circulating GH concentrations also promotes adipose tissue mobilization, 
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increasing release of non-esterified fatty acids (NEFA), which help support the energy 
requirements of lactation (Butler et al., 2003).   
In addition to NEBAL, systemic inflammation is another common characteristic of the 
transition period in dairy cattle. Inflammation frequently begins in the uterus during parturition, 
but can also affect other tissues such as the liver and adipose tissue (Loor et al., 2005; Bradford et 
al., 2015), instigating the acute phase response. This causes the pro-inflammatory cytokine tumor 
necrosis factor alpha (TNFα), produced by macrophages and mast cells in response to 
inflammatory stimuli, to induce the production and release of liver acute phase proteins (APP; 
Paltrinieri, 2008; Bannerman et al., 2009; Cray et al., 2009). Whereas some degree of inflammation 
is necessary to repair tissue damage from parturition and fight disease, prolonged or highly 
elevated levels of APP, such as haptoglobin, during this early lactation period have been shown to 
negatively affect animal health and productivity (Huzzey et al., 2009 and 2015).  
Improving feeding and management strategies to support the metabolic adaptations in 
transition cows are critical steps to increase the productivity and profitability of a dairy through 
minimizing economic loss due to subclinical and clinical metabolic disorders (Overton and 
Waldron, 2004). Feeding higher starch diets is a common strategy to maximize energy intake, but 
may cause inflammation in the rumen due to a low rumen pH (Plaizer et al., 2007; Williams et al., 
2015). One possible method of preventing this low rumen pH is to feed a high starch diet in 
combination with high fiber. Increased fiber intake could help play a role in keeping cows healthy 
by maintaining a healthy rumen, decreasing systemic inflammation, and improving metabolic 
status when fed in conjunction with a high starch diet (McCarthy et al., 2014). The objective of 
my thesis was to specifically examine the effect of feeding high fiber diets in combination with 
high starch on hepatic metabolism, namely hepatic gene expression of IGF-I, GHR, TNFα, and 
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TNFα receptor (TNFRSF1a) in lactating cows, with the goal of minimizing NEBAL and systemic 
inflammation during the early postpartum period.  Since genotype data was available from a 
previous trial, I also wanted to analyze the effect of IGF-I, GHR, and TNFα genotype on hepatic 
gene expression. Finally, I wanted to determine if there was any significant correlation between 
hepatic gene expression and other variables related to energy balance, metabolism, and liver 
health.  
 
Review of the Literature  
 
Introduction  
 
For decades, nutrients have traditionally been defined as fuel, building blocks, and 
enzymatic cofactors (Bradford, 2018). This understanding led to the construction of various 
determination systems to assess the nutrient requirements of livestock (Thornton, 2010), including 
the National Research Council’s (NRC) first nutrient requirement tables for farm and laboratory 
animals published in 1944. These guidelines have been subsequently updated when deemed 
necessary, and used as the standard for animal diet formulation around the globe (Coffey et al., 
2016). While this method of feeding livestock has certainly been beneficial, it fails to reflect the 
full impact of nutrients within an animal’s body. Nutrients are not only basic fuels but also 
bioactive signals that exert direct effects on cellular function, chromatin structure, and overall 
animal physiology (Bradford, 2018). This occurs through interactions not merely within a cow’s 
digestive system but throughout every system in her body.  
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At this point in time, all nutrient classes have been deemed capable to signal in an 
endocrine-like manner, resulting in a much more complex endocrine network than previously 
understood (Bradford, 2018). This network includes hormones released by adipose tissue, liver, 
muscle, and even bone to regulate appetite, nutrient partitioning, and nutrient mobilization. The 
liver particularly plays an essential role in the coordination of nutrient partitioning, allowing for 
the adjustment of metabolism to supply the needs of other tissues throughout the body (Drackley 
et al., 2001).  The biggest impact of these discoveries lies in the potential to improve feeding 
strategies for physiologically stressed animals, including those that are heat-stressed, transitioning 
to lactation, or ill, to improve animal production and resilience (Bradford 2018). The following 
review of the literature will focus on the metabolic and physiological adaptations associated with 
the transition to lactation for dairy cattle, specifically in regards to hepatic metabolism of glucose, 
insulin, and GH during NEBAL. It will also review current and potential nutritional strategies to 
address and minimize the effects of NEBAL and systemic inflammation during the early 
postpartum period. 
 
The Transition to Lactation  
 
Milk production per cow in the United States over the last 100 years has steadily increased, 
mainly due to continuous improvements in nutritional management and genetic selection 
(VandeHaar and St-Pierre 2006). This trend is only expected to continue; in the last ten years 
alone, the average production per cow has increased 13%, leading the average cow to produce over 
23,000 pounds of milk per year (USDA-NASS, 2019). While this drastic increase in production is 
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a huge accomplishment for dairy producers, it does not come without its challenges, especially 
during the transition to lactation.  
The transition period, defined as 3 weeks before to 3 weeks after calving (Grummer, 1995), 
is a time of major metabolic adaptations throughout a cow’s body. Predicted demands for glucose, 
amino acids, and fatty acids by the lactating mammary gland at four days in milk (DIM) are about 
2.7, 2.0, and 4.5 times those of the gravid uterus during late pregnancy (Bell, 1995).  A cow’s dry 
matter intake (DMI) increases postpartum, but is insufficient to meet the immediate energetic costs 
of milk production, which leaves her in a prolonged state of NEBAL in early lactation (Bell, 1995; 
Butler et al, 2003).  
Negative energy balance is characterized by extensive mobilization of stored adipose 
reserves into circulation as NEFA to meet the increased demand for nutrients (Morris et al., 2009; 
Ospina, 2010). These NEFA can be fully or partially oxidized in the liver (Newman and Verdin, 
2017), stored as liver triglycerides (Gruenberg, 2019), used for milk fat synthesis, or used as an 
alternative fuel source for muscle tissues in times of low blood glucose (Drackley et al., 2001). 
Some hepatic lipid accumulation during the transition period is a normal adaptation to lactation 
(Grum et al., 1996), but excessive triglyceride accumulation in the liver has been demonstrated to 
impair hepatic metabolism (Strang et al., 1998).  
Fatty acids that are partially oxidized in the liver can be released into circulation as beta-
hydroxybutyrate (BHB) or other ketone bodies as energy sources for peripheral tissues when 
glucose supply is too low to meet energy needs (Newman and Verdin, 2017). Incomplete hepatic 
oxidation of NEFA can lead to an increase in reactive oxygen species (ROS) and oxidative stress, 
which can disrupt normal metabolism and can lead to immunosuppression in the already 
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compromised animal (Morris et al., 2009). High levels of circulating NEFA, BHB, as well as 
hepatic triglycerides characterizes ketosis (Xiliang et al., 2017), a metabolic disease common to 
the transition period. Given this increase of ROS and oxidative stress in combination with 
insufficient DMI, elevated circulating NEFA increases the risk for a number of other transition 
diseases as well, including displaced abomasum, retained placenta, and metritis (Ospina et al., 
2010).  
 
Energy Metabolism in the Transition Cow  
 
Ruminants are obligate herbivores that use pregastric fermentative digestion to utilize 
cellulose and other fibrous feed components. During the process of microbial fermentation, rumen 
microbes consume much of the readily digestible nutrients in a cow’s diet and produce volatile 
fatty acids (VFA), such as propionate, as a byproduct of pregastric fermentation (Bell and Bauman, 
1997). These VFA are absorbed by the ruminal epithelium into portal venous blood and removed 
by the liver for metabolism (Elliot, 1980; Brockman, 1993). Hepatic supply of propionate is a 
principal determinant of hepatic glucose synthesis (Brockman, 1993). This means that there is a 
strong correlation between digestible energy intake and whole-body glucose production in the 
dairy cow. Moreover, the dairy cow depends almost entirely on hepatic gluconeogenesis from the 
byproducts of pregastric fermentation to meet tissue glucose requirements (Bell and Bauman 1997; 
Elliot, 1980; Brockman, 1993).  
Requirements for glucose increase by 2.7 times after calving compared to late pregnancy 
(Bell, 1995), and the source of this demand shifts location from the gravid uterus to the mammary 
gland (Bell, 1995; Bell and Bauman, 1997). This shift in nutrient demand is largely due to the 
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particularly high glucose demand of the mammary gland to synthesize lactose, the main osmotic 
determinant of milk volume (Bell and Bauman, 1997). The liver must therefore adapt quickly to 
provide the increased glucose requirements for milk production, and to process high concentrations 
of NEFAs from adipose tissue mobilization during NEBAL (Drackley et al., 2001). To meet this 
high demand for glucose, hepatic gluconeogenesis must increase despite the lack of substantial 
increase in DMI (Paterson and Linzell, 1974; Bauman and Elliot, 1983). The difference between 
glucose from digestible energy intake and the cow’s glucose demand must be made up from non-
carbohydrate sources. These include intestinally absorbed amino acids and endogenous substrates 
such as amino acids, lactate, and glycerol (Drackley et al., 2001). All amino acids except for 
leucine and lysine are able to contribute to gluconeogenesis, but alanine and glutamine are the 
greatest contributors. Most fatty acids, on the other hand, are not able to be directly used for 
glucose synthesis. Instead, they oxidize long chain fatty acids such as NEFAs to ketone bodies, 
which provide ATP needed for gluconeogenesis (Drackley et al., 2001). The mammary gland’s 
high demand for glucose, combined with a variety of limited sources of glucose and energy, makes 
proper nutrient partitioning critical to ensure that glucose produced by the liver is utilized primarily 
by the mammary gland and not peripheral tissues.  
 
Endocrine Control of Nutrient Partitioning  
 
Insulin is a key mediator of nutrient partitioning, helping to maintain metabolic equilibrium 
during variations in nutrient supply and demand. Plasma insulin levels specifically play a role in 
the mediation of chronic metabolic adaptations to pregnancy and lactation, including altering the 
hepatic production and peripheral utilization of glucose (Bell and Bauman, 1997). Lowering 
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plasma insulin levels around parturition is a metabolic tactic employed by the high producing dairy 
cow as a response to low blood glucose levels. This allows for the reduction of glucose uptake by 
insulin-responsive peripheral tissues, such as adipose tissue and muscle, in order to facilitate 
greater uptake of glucose by the non-insulin responsive mammary gland (Bauman and Elliot, 
1983). Growth hormone is also key during this period, as it plays a role in altering tissue responses 
to insulin, providing further regulation of glucose utilization (Bell and Bauman, 1997). The 
coordination of low insulin, high GH, and low glucose is a characteristic of postpartum NEBAL 
(Butler et al., 2003). In general, these homeorhetic adaptations persist throughout early lactation, 
but decrease as voluntary feed intake increases several weeks after peak milk yield (Bell and 
Bauman, 1997), placing the cow once again in a positive energy balance. 
A primary response to circulating GH is the production of IGF-I, a polypeptide produced 
primarily by the liver when GH binds to GHR on the surface of hepatocytes (Yakar et al., 2002; 
Butler et al., 2003; Jones and Clemmons, 1995). IGF-I has multiple biological effects, including 
regulating the metabolism of peripheral tissues (White, 2014) and enhancing insulin sensitivity 
(Yakar et al., 2001). Hepatic expression of IGF-I and GHR is therefore acutely responsive to the 
cow’s nutritional status (Bornfeldt et al., 1989; Pell et al., 1993) and physiological state (Kobayashi 
et al., 1999). During NEBAL, plasma insulin levels are lowered, which lowers hepatic GHR 
concentrations and renders the liver resistant to circulating GH. As a result, hepatic IGF-I 
production is low despite high GH concentrations, uncoupling the GH-IGF-I axis (Figure 1; Butler 
et al., 2003). Decreased plasma insulin (Butler et al., 2003) and decreased insulin sensitivity due 
to lower IGF-I production (Yakar et al., 2001) allows for glucose uptake to be dominated by the 
noninsulin-sensitive mammary gland instead of insulin-sensitive peripheral tissues (Bell and 
Bauman, 1997).  
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Adipose tissue has the opposite response to hypoinsulinemia when compared to a 
hepatocyte; GHR expression is up-regulated, which results in GH-stimulated adipose tissue 
mobilization (Figure 1). High levels of circulating GH and low levels of insulin are common in 
early lactation cows in NEBAL, and these conditions favor adipose tissue mobilization in support 
of milk production (Butler et al., 2003). Mobilizing greater amounts of body reserves in early 
lactation increases the release of NEFA into circulation, placing cows at greater risk of transition 
diseases (Ospina et al. 2010).  
 
Figure 1. The effect of low plasma insulin in liver and adipose tissue. Low plasma insulin causes 
a reduction of cell surface growth hormone receptors (GHR), which reduces insulin-like growth 
factor (IGF-I) expression. Plasma IGF-I levels are reduced and plasma GH is raised as a result of 
this “GH-resistance” of the liver. Hypoinsulinemia has the opposite effect on adipose tissue, 
increasing GHR expression and the number of cell surface GHR, which encourages GH-stimulated 
lipolysis.  
 
Systemic Inflammation during the Transition Period  
 
In addition to NEBAL, systemic inflammation is another characteristic of the transition 
period in response to infection, tissue injury, and other stressors (Bradford et al., 2015). The 
(Adapted from Butler et al., 2003) 
16 
 
 
proinflammatory cytokine TNFα, which is produced by macrophages and mast cells during acute 
inflammation, is one of the most important cytokines that trigger the acute phase response as a 
reaction to inflammatory stimuli (Moshage, 1997; Bannerman et al., 2009). Immune system 
activation is an energetically demanding process, requiring a reallocation of nutrients from growth 
and productive functions (Bradford et al., 2015). Studies have associated the postpartum acute-
phase response with negative lactation outcomes, and have also shown a delayed resolution of 
inflammation in cows with greater peak concentrations of inflammatory markers (Bionaz et al., 
2007). It is therefore in the best interest of producers to minimize inflammation to not only be 
cognizant of animal welfare, but to increase the productive profitability of each animal 
transitioning to lactation.  
Pathogen recognition from infections such as metritis and mastitis are among the most 
noticeable causes of inflammation during this transition period. Although there is a high incidence 
of morbidity during the first few weeks of lactation, a number of studies have shown that 
inflammatory and positive acute phase mediators are elevated in the days following parturition, 
even in the absence of disease (Bionaz et al., 2007; Huzzey et al., 2009; Graugnard et al., 2012; 
Mullins et al., 2012; Akbar et al., 2015 from Bradford 2015). This non-infectious inflammation 
can be a response to uterine damage during parturition, hepatic oxidative stress, or the need for 
adipose tissue mobilization during NEBAL.  
Tissue damage in the endometrium and cervix during parturition is often the beginning of 
postpartum inflammation (Bradford et al., 2015; Bromfield et al., 2015). Even healthy animals 
experience some degree of inflammation to repair uterine tissue, which can lead to a systemic 
inflammatory condition postcalving (Bradford et al., 2015). This pattern of systemic inflammation 
from uterine injury has been documented in humans following parturition as well (Elliot et al., 
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2001), and can affect the inflammatory status of other tissues throughout the body (Bradford et al., 
2015). In addition to inflammation due to tissue repair, nearly half of all postpartum dairy cattle 
experience further inflammation from clinical metritis or endometritis (Bromfield et al., 2015). 
The liver is another major tissue that experiences inflammation during the transition period. 
TNFα is an important pro-inflammatory cytokine in the liver, and has been shown to increase in 
hepatic expression for weeks leading up to and following parturition (Loor et al., 2005). Loor et 
al. (2005), showed a significant increase in hepatic TNFα expression from day -65 to day 1 relative 
to parturition, and another significant increase on day 49 compared to all previous time points. The 
acute phase response instigated by TNFα results in altered hepatic protein production; negative 
APP are those such as albumin that decrease in production during the acute phase response, while 
positive APP are those such as haptoglobin that are produced in greater quantities during the acute 
phase response. (Cray et al., 2009; Paltrinieri, 2008; Bertoni and Trevesi 2013). These APP 
perform many physiological functions within the immune system. Haptoglobin, for example, binds 
with high affinity to free hemoglobin, inhibiting toxic oxidative activity (Schaer et al., 2014). 
Whereas some degree of inflammation and APP production is necessary to repair tissues damage 
from parturition and to fight disease (Huzzey et al., 2009), elevated (>1 g/L) levels of haptoglobin 
were associated with 464 kg less milk during lactation and a twenty percent decrease in pregnancy 
risk during the first 150 days in milk (Huzzey et al., 2015).  
Adipose tissue transcription of pro-inflammatory cytokines, such as TNFα, are upregulated 
during the transition period as well. Adipose TNFα transcription peaks when the surge in adipose 
tissue lipolysis, measured by free fatty acids in circulation, is observed (Sadri et al., 2009; Schmitt 
et al., 2011; Mann et al., 2016). Loor et al. (2005) showed that increased hepatic expression of 
TNFα and APP is positively correlated with lipid mobilization from adipose tissue (increased 
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plasma NEFA) and fatty acid oxidation (increased plasma BHB). While there is still significant 
work to be done in understanding the relationship between hepatic and adipose tissue TNFα 
expression, these correlations further support the combined challenge of NEBAL and systemic 
inflammation during the transition period.  
Evidence from a variety of species indicates that TNFα not only affects systemic 
inflammation, but can alter the GH-IGF-I axis as well (Briard et al., 2000; Kushibiki et al., 2003; 
Blum et al., 2018). Pro-inflammatory cytokines, such as TNFα, are known to disrupt the GH-IGF-
I axis in humans (Blum et al., 2018). This disruption comes from the interference of circulating 
IGF-I production, resulting in hepatic GH resistance (Zhao et al., 2014 Blum 2018 ref 22), and 
from cytokine interference with the action of locally produced IGF-I (Choukair et al., 2014). Briard 
et al. (2000) suggests that the acute phase response may combine with hypoinsulinemia in altering 
the GH-IGF-I axis in ruminants as well. Lipopolysaccharide (LPS) challenge induced a rapid 
increase in plasma concentration of inflammatory cytokines, including TNFα, resulting in 
increased circulating GH concentrations and decreased circulating IGF-I concentrations in sheep. 
Specifically in lactating dairy cattle, recombinant TNFα administered subcutaneously has been 
shown to decrease feed intake (Kushibiki et al., 2003). This places cows into greater NEBAL and 
can further uncouple the GH-IGF-I axis. 
 
Dietary Interventions  
 
Improving feeding strategies for physiologically stressed animals in the transition period 
is one of the most critical steps forward in increasing the productivity and profitability of a dairy. 
Complications during the transition period not only affect current health of cows but impedes 
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ability to perform to their potential well into lactation (LeBlanc, 2010). Like any animal, a dairy 
cow has limited resources; if output increases for lactation, other energetic processes that maintain 
health and fertility are downregulated (Oltenacu and Algers, 2005). Proper nutrition that 
successfully transitions a cow from the demands of late pregnancy to early lactation has the 
potential to mitigate many of the early lactation complications described above, through reducing 
the duration and severity of NEBAL as well as decreasing systemic inflammation.  
Maximizing DMI immediately post calving logically mitigates NEBAL and therefore 
decreases the risk of periparturient disease. Feeding higher starch rations has been reported to not 
only increase energy availability due to the increased supply of glucose precursors supplied in the 
diet, but also increase overall DMI and decrease circulating NEFA in the early postpartum period 
(Anderson et al., 2003; Rabelo et al., 2003; McCarthy et al., 2015b and 2015c). This increase in 
DMI is a likely due to the reduced physical fill of high concentrate diets in combination with 
reduced NEFA mobilization for energy (Drackley et al., 2001). Although increasing starch can 
increase DMI, cows fed a higher starch diet during the first three weeks of lactation could also 
have a higher risk of sub-acute ruminal acidosis (SARA; Williams et al., 2015), a condition where 
ruminal pH is depressed due to accumulation of VFA and insufficient rumen buffering. 
Consequences of SARA can include decreased DMI, decreased fiber digestion, milk fat 
depression, diarrhea, laminitis, liver abscesses, and possible inflammation characterized by 
increased circulating APP (Plaizer et al., 2007).  
One possible method of preventing SARA in cows fed high starch rations is to feed high 
starch in combination with different pools of fiber. Physically effective neutral detergent fiber 
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(peNDF1), defined as the fraction of fiber that stimulates chewing and contributes to the floating 
mat of particles in the rumen, increases chewing and rumination time (Mertens, 1997). Additional 
peNDF in a diet may help to minimize SARA through increased production of salivary bicarbonate 
(Stone, 2004), though its specific impact on the transition period has not been defined (LaCount 
et al., 2017). Undigested neutral detergent fiber (uNDF240), defined as fiber remaining after 240 h 
of in vitro fermentation, has recently been examined as a possible metric related to DMI and rumen 
health in mid-lactation diets (Cotanch et al., 2014). A ration with too low uNDF240 could 
compromise rumen health and increase risk for SARA, but one too high in uNDF240 could limit 
intake due to physical fill (LaCount et al. 2017). Feeding a diet on either end of the uNDF240 
spectrum could place early lactation animals further into NEBAL. Case studies from our lab 
suggest that early postpartum cows fed a high starch diet in conjunction with higher uNDF240 
(10.7% of ration DM, intake 0.36% of BW) had higher DMI and improved health when compared 
to those fed low uNDF240 (8.3% of ration DM, intake 0.27% of BW), as cows fed the lower 
uNDF240 had higher incidences of metabolic disorders (McCarthy et al., 2014). The limited but 
promising evidence of the effect of uNDF, combined with peNDF impacts on intake and rumen 
dynamics, indicate that increased fiber could help play a role in keeping cows healthy through 
maintaining a healthy rumen environment and possibly decreasing inflammation, while improving 
metabolic status when fed in conjunction with a high starch diet. This improved metabolic status 
could help cows decrease NEBAL, bringing the uncoupled GH-IGF-I axis closer to what exists 
during times of positive energy balance.   
                                                          
 
1 Estimated by calculating percent of particles that remain above the 4mm sieve when using the Penn State Particle 
Separator  
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Research Objectives 
 
Understanding how to best use fiber pools in the early lactation ration has the potential to 
improve animal health and productivity during this stressful transition period. Feeding higher 
starch early lactation rations in combination with higher fiber could increase DMI and glucose 
availability while decreasing risk and impacts of SARA. This could decrease the extent and 
duration of NEBAL, improve metabolic status, and decrease systemic inflammation postpartum. 
The objective of my thesis was to specifically examine the effect of high fiber dietary intervention 
on hepatic metabolism of lactating dairy cows, namely hepatic gene expression of IGF-I, GHR, 
TNFα, and TNFα receptor (TNFRSF1a), with the goal of minimizing NEBAL and systemic 
inflammation during the early postpartum period. My hypothesis was that cows fed the high fiber 
diet would have reduced inflammation (marked by lower TNFα and TNFRSF1a expression), and 
an increase in overall energy balance (marked by an increase in IGF-I and GHR expression). While 
examining the effect of diet on hepatic gene expression, I also wanted to analyze the effect of 
genotype and other information collected throughout the study related to energy balance, 
metabolism, and liver health on the hepatic expression of these genes.  
 
Methodology 
 
Overview of the Animal Trial 
 
This project involved analyzing liver samples collected from cows that were part of a 
previously conducted experiment studying the effects of varying undigested neutral detergent fiber 
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(uNDF240) and physically effective neutral detergent fiber (peNDF) content of fresh rations on 
cow performance and metabolism (LaCount et al., 2017). All procedures involving animals were 
approved by the Cornell University Institutional Animal Care and Use Committee. Multiparous 
Holstein cows (n=40) were fed a common prepartum ration beginning 28 d prior to expected 
parturition and assigned randomly at calving to one of two postpartum diets differing in fiber 
content. The high fiber (35.3% NDF, 12.2% uNDF240, 23.2% peNDF; n=19) and low fiber (32.8% 
NDF, 9.5% uNDF240, 21.6% peNDF; n=21) treatment diets were formulated for equivalent 
metabolizable protein and starch concentrations. Cows were fed their respective treatment diets 
from calving through d 28 postpartum. After calving, all cows were milked 3 times daily at 0600, 
1400, and 2200 h.  
Feed Management and Sampling 
 
Cows were housed in tiestalls throughout the duration of the study. They were fed daily 
between the hours of 0700 and 0900 h, with individual feed intake measured on a daily basis 
through weighing feed delivered and feed refused. Refusal rates were targeted at 10% to allow for 
ad libitum intake throughout the study. Cornell Net Carbohydrate and Protein System (CNCPS, 
version 6.5, Cornell University, Ithaca, NY) was used to formulate rations. Ingredient composition 
and analyzed diet composition of all prepartum and postpartum treatment diets are presented in 
Tables 1 and 2, respectively.  
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Table 1. Formulated ingredient composition of the common prepartum diet and postpartum 
treatment diets formulated to differ in amount of undigested NDF at 240-h of in vitro fermentation 
(uNDF240) and physically effective NDF (peNDF).   
Prepartum Diet 
Postpartum Diet1 
Ingredient, % of DM LF 1 HF 1 
Conventional corn silage  45.19  42.31  38.46 
Alfalfa hay  -  10.58  10.58 
Straw  20.84  1.15  8.65 
Corn meal  2.43  17.64  20.51 
Soybean meal  -  6.03  4.72 
Canola meal  3.48  4.52  3.88 
Wheat middlings  -  4.82  1.62 
Amino Plus2  5.91  4.35  5.32 
Corn gluten feed  1.74  1.60  0.47 
Blood meal  2.43  0.95  1.09 
Soybean hulls  6.95  2.42  - 
Citrus pulp  4.52  -  0.79 
Energy Booster3  -  1.29  1.57 
Rumensin4    0.10  0.05  0.05 
Salt  -  0.48  0.47 
Ca Carbonate  2.26  1.13  1.18 
Mg Oxide  -  0.28  0.28 
Animate5  3.13  -  - 
Alimet6  0.07  -  - 
Vitamin and mineral mix7  0.94  0.40  0.39 
1Treatments: low fiber (LF; uNDF240 = 9.5% of DM, peNDF = 21% of DM), high fiber (HF; 
uNDF240 = 12.2% of DM, peNDF = 23% of DM). Treatment diets were fed from wk 1 to 4 after 
which all cows were switched to the LF diet. 
2 Heat-treated soybean meal, Ag Processing Inc., Omaha, NE.  
3 Commercial fat source, Milk Specialties Global, Eden Prairie, MN.  
4 Premix contained 26,400 g/t of monensin, Elanco Animal Health, Greenfield, IN.   
5 Anionic mineral supplement, Phibro Animal Health Corporation, Teaneck, NJ.  
6 2-Hydroxy-4-(methylthio)-butanoic acid, Novus International, Saint Charles, MO. 
7 Prepartum mix contained 3,754 mg/kg Zn, 993 mg/kg Cu, 4,658 mg/kg Mn, 28.9 mg/kg Se, 82.8 
mg/kg Co, 82.4 mg/kg I, 1,177 KIU/kg Vitamin A, 253 KIU/kg Vitamin D, and 55,784 IU/kg 
Vitamin E. Postpartum mix contained 25,560 mg/kg Zn, 7,154 mg/kg Cu, 21,958 mg/kg Mn, 214 
mg/kg Se, 507 mg/kg Co, 331 mg/kg I, 3,704 KIU/kg Vitamin A, 922 KIU/kg Vitamin D, and 
12,496 IU/kg Vitamin E (Central New York Feeds, Jordan, NY). 
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Table 2. Nutrient profile of all rations (mean ± SD), obtained through wet chemistry analysis and 
in vitro fermentation by Cumberland Valley Analytical Services (Hagerstown, MD), predicted by 
Cornell Net Carbohydrate and Protein System (version 6.5, Cornell University, Ithaca, NY), and 
obtained with a Penn State Particle Separator (Nasco Inc., Fort Watkinson, WI).  
Diet 
Item Prepartum Low Fiber  (LF)1 High Fiber  (HF)1 
DM, % as fed2  45.9 ± 1.2  44.4 ± 2.2  47.4 ± 2.0 
ADF, % DM  29.0 ± 0.5  21.3 ± 1.1  22.9 ± 2.1 
aNDFom, % DM  43.1 ± 0.3  32.8 ± 1.4  35.3 ± 2.3 
30-h NDFD3, % DM  24.2 ± 0.5  20.2 ± 0.5  19.1 ± 1.7 
30-h NDFD, % NDF  54.4 ± 1.5  59.5 ± 1.0  52.6 ± 2.2 
uNDF240
4
, % DM  12.8 ± 0.5  9.5 ± 0.4  12.2 ± 1.6 
CP, %  14.1 ± 0.8  15.5 ± 0.5  13.8 ± 1.4 
Starch, %  15.7 ± 0.3  24.9 ± 1.7  24.6 ± 2.3 
Sugar, %  3.5 ±  0.4  5.1 ±  0.7  3.9 ±  0.1 
Fat, %  2.3 ± 0.2  3.3 ± 0.2  3.2 ± 0.2 
peNDF5, %  33.36  21.67  23.27 
MP6, g/kg DM  89.0  112.1  108.0 
NEL, Mcal/kg   1.45 ± 0.02  1.65 ± 0.03  1.61 ± 0.02 
Ca, %  1.46 ± 0.07  0.97 ± 0.12  0.98 ± 0.19 
P, %  0.32 ± 0.02  0.41 ± 0.01  0.37 ± 0.01 
Mg, %  0.51 ± 0.02  0.40 ± 0.04  0.39 ± 0.04 
K, %  1.16 ± 0.02  1.24 ± 0.03  1.21 ± 0.04 
S, %  0.39 ± 0.02  0.30 ± 0.02  0.26 ± 0.02 
Na, %  0.13 ± 0.01  0.26 ± 0.02  0.23 ± 0.03 
Cl, %  0.67 ± 0.02  0.49 ± 0.02  0.44 ± 0.04 
1 Treatments: low fiber (LF; uNDF240 = 9.5% of DM, peNDF = 21% of DM), high fiber (HF; 
uNDF240 = 12.2% of DM, peNDF = 23% of DM). Treatment diets were fed from wk 1 to 4 after 
which all cows were switched to the LF diet.  
2 Determined via wet chemistry from fresh weekly samples sent to Cumberland Valley Analytical 
Services for NIR analysis. 
3 NDF digestibility, determined via in vitro fermentation 
4 Undigested NDF at 240-h of in vitro fermentation  
5 Physically effective NDF  
6 Formulated value given by Cornell Net Carbohydrate and Protein System v. 6.5 using analyzed 
forage values and mean DMI for each period and treatment. 
7 Determined using a Penn State Particle Separator from two samples collected throughout the 
study. Value obtained by multiplying the percentage of sample retained on screens ≥ 4mm by the 
ration NDF content. 
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Samples of all feed ingredients and total mixed rations (TMR) were collected weekly for 
determination of dry matter (DM), and were dried at 40°C for 96 h in a forced-air oven. As-fed 
inclusion rates of all forages and grain ingredients were adjusted based on these weekly DM values. 
At the end of the experiment, dried samples were ground through a 2-mm screen in a Wiley mill 
and composited for later wet chemistry analysis.  
 
Individual Animal Sampling  
 
Liver tissue (3–5 g) was sampled via percutaneous trocar biopsy (Veenhuizen et al., 1991) 
on day 7 ± 1.1  and 14 ± 1.0 (mean ± SD) postpartum from cows under local anesthesia. After 
blotting the liver sample to remove excess blood and connective tissue the liver sample was snap 
frozen in liquid N2 and stored at -80°C until analysis of glycogen, triglycerides, and RNA isolation 
for gene expression analysis. 
Blood samples were collected between the hours of 0600 and 0730 daily from 0 to 7 DIM, 
and 3x/wk through 28 DIM. Samples were collected via coccygeal venipuncture using 10-mL 
sodium heparin evacuated tubes (158 USP, Becton Dickinson and Company, Franklin Lakes, NJ) 
and 20 G vacutainer needles (Becton Dickinson and Company) and placed on ice immediately 
after collection. Plasma was harvested after centrifugation at 2,000 × g for 20 min at 4°C, aliquoted 
into 1.7-mL microfuge tubes, snap frozen in liquid nitrogen, and stored at −20°C until later 
analysis.  
Milk samples were collected at 3 consecutive milkings each week. After collection, they 
were mixed with a bronopol preservative and stored at 4°C until transportation within 72h of 
collection to a commercial laboratory (DairyOne, Ithaca, NY). Milk weights were recorded daily. 
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Daily milk yield was calculated as the sum of yields at all 3 milkings and used to determine average 
milk production per week, as well as total average milk production from d 0 through d 14.   
 
Calculating Energy Balance  
 
Energy balance was determined weekly according to NRC (2001) equations for the 
following: energy intake (Mcal/d) = weekly DMI average (kg/d) × diet net energy of lactation 
(NEL; Mcal/kg of DM), maintenance requirement (Mcal) = week metabolic body weight (BW) 
(kg0.75) × 0.08 (Mcal/kg0.75 per d), and lactation requirement (Mcal/d) = wk average milk yield 
(kg/d) × [(0.0929 × fat percentage) + (0.0563 × true protein percentage) + (0.0395 × lactose 
percentage)]. Weekly energy balance was calculated as follows: 
Postpartum NEL (Mcal/d) balance = energy intake (Mcal of NEL/d) – [maintenance 
requirement (Mcal of NEL/d) + lactation requirement (Mcal of NEL/d)]. 
 
Laboratory Methods  
 
Composited feed samples were sent to a commercial laboratory (Cumberland Valley 
Analytical Services, Hagerstown, MD) for wet chemistry analysis of DM  at 135°C (method 
930.15, AOAC International, 2000), crude protein (CP; method 990.03, AOAC International, 
2000), acid detergent fiber (ADF; method 973.18, AOAC International, 2000), neutral detergent 
fiber (NDF; Van Soest et al., 1991), starch (Hall, 2009), sugar (Dubois et al., 1956), ether extract 
(method 2003.05, AOAC International, 2006), and minerals (method 985.01, AOAC International, 
2000). Values for NEL of TMR composite samples were calculated according to NRC (2001).   
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 Milk samples were analyzed at a commercial laboratory (DairyOne, Ithaca, NY) for milk 
fat, protein, lactose, total solids (TS), and milk urea nitrogen (MUN) using mid-infrared techniques 
(method 972.16, AOAC International, 2006). 
Plasma samples taken on the day corresponding with liver biopsy were sent to a 
commercial diagnostic lab for analysis (University of Guelph Animal Health Laboratory, Guelph, 
ON, Canada) of haptoglobin based on peroxidase activity (Makimura and Suzuki, 1982, Skinner 
et al., 1991), and aspartate aminotransferase (AST), cholesterol, glutamate dehydrogenase 
(GLDH), gamma-glutamyltransferase (GGT), bilirubin, total protein, albumin, globulin, and 
albumin:globulin ratio on a Roche Cobas 6000 c501 biochemistry analyzer (Roche Diagnostics, 
Indianapolis, IN) according to the manufacturer’s instructions.  
 Plasma IGF-I concentrations were assayed using the radioimmunoassay procedure 
described by Butler et al. (2003) following the extraction procedure described in Butler et al. 
(2004). Analysis of plasma NEFA concentrations [HR Series NEFA HR (2), Wako Pure Chemical 
Industries, Osaka, Japan], and plasma beta-hydroxybutyrate (BHB) (Catachem Inc., Oxford, CT) 
were conducted in triplicate using commercial enzymatic kits, as described in Leno et al. (2017). 
Plasma glucose concentrations were determined by enzymatic analysis (glucose oxidase; protocol 
from kit 510-A; Sigma-Aldrich, St. Louis, MO) using commercial products (PGO Enzyme 
Preparation and o-dianisidine dihydrochloride, Sigma-Aldrich) as described in McCarthy et al. 
(2015c). Coefficients of variation for all assays (both inter- and intra-assay) were maintained 
below 10%. 
Liver samples were analyzed for triglycerides using the Folch extraction method (Folch et 
al., 1957), followed by a colorimetric method for estimating serum triglyceride based upon the 
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Hantzsch condensation (Fletcher, 1968) with modifications described by Foster and Dunn (1973). 
Glycogen content of liver was determined by following procedures as described by Bernal-Santos 
et al. (2003).  
DNA genotyping was completed for all IGF-I, GHR, and TNFα SNPs using PCR-
restriction fragment length (PCR-RFLP) methods, as described in Hax et al., 2017 and Higuchi et 
al., 1999. Primers, annealing temperature, fragment lengths, and enzymes used can be found in 
Table 3. The genotype of each animal was determined by the fragment size reported as base pairs. 
The genotypes identified for IGF-I were: SnaBI (A/A) 249bp; SnaBI (A/B) 249bp, 226 bp; SnaBI 
(B/B) 226bp (Ge et al., 2011). The genotypes identified for GHR were: AluI (A/A) 747 bp, 75 bp; 
AluI (A/B) 747 bp, 602 bp, 145 bp, 75 bp; AluI (B/B) 602 bp, 145 bp, 75 bp (Aggrey et al., 1999). 
The genotypes identified for TNFα were: Allele A: 1233bp; Allele B: 928 bp, 305 bp (Higuchi et 
al., 1999).    
Table 3. Primers, annealing temperatures, and enzymes used to genotype insulin-like growth 
factor one (IGF-I), growth hormone receptor (GHR), and tumor necrosis factor alpha (TNFα) 
genes 
Gene Annealing T° Fragment length Enzyme Reference 
IGF-I primers 
FW: TTAAATAATTGGGTTGGAAGACTGC 
RV: ACCTTACCCGTATGAAAGGAATATACGT 
58 °C 249 bp SnaBI Ge et al., 2011 
GHR primers  
FW: TGCGTGCACAGCAGCTCAACC 
RV: AGCAACCCCACTGCTGGGCAT 
66 °C 836 bp AluI Aggrey et al., 1999 
TNFα primers 
FW: GGGTGACTTGCTCTAACACTCATC 
RV: AGGCCTCACTTCCCTACATCCCTA 
63 °C 1233 bp RsaI Higuchi et al., 1999 
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Hepatic gene expression of IGF-I, GHR, TNFα, and TNFRSF1a was determined as a 
measure of relative quantification using quantitative PCR. Total RNA was isolated and purified 
for RT-qPCR using miRNeasy minicolumns and on-column ribonuclease-free deoxyribonuclease 
treatment (QIAGEN Inc., Hilden, Germany). Quantity and integrity of RNA was determined using 
the RNA Nano Lab chip kit and 2100 bioanalyzer system (Agilent, Santa Clara, CA). 
 Reverse transcriptase reactions were performed with 2 µg of RNA in a 20-µL volume using 
the high capacity cDNA reverse transcription kit with RNase Inhibitor (Applied Biosystems, 
Foster City, CA) according to the manufacturer’s recommendation. Quantitative PCR reactions 
were prepared in duplicate according to recommendations for the use of Taqman Fast Advanced 
Gene Expression master mix on a StepOne Plus instrument (Applied Biosystems). Specifically, 
each well consisted of 10 µL of Taqman Fast Advanced master mix, 1 µL of Taqman assay, 7 µL 
of sterile H2O, and 2 µL of 10-fold diluted cDNA for a total volume of 20 µL per well. A single 
control reaction using 2 µL of sterile H2O was included for each gene on every plate. All Taqman 
probes for genes of interest were selected to span exon junctions and not detect genomic DNA and 
were purchased from Applied Biosystems (Foster City, CA): insulin-like growth factor one (IGF-
I; assay Bt03252282), growth hormone receptor (GHR; assay Bt03216844), tumor necrosis factor 
alpha (TNFα; assay Bt03259156), and tumor necrosis factor alpha receptor super family one alpha 
(TNFSRF1a; assay Bt03215763). In addition, two references genes were selected: large ribosomal 
protein P0 (RPLP0; Bt03218086) and TATA box binding protein (TBP; Bt03241948).  
Cycles were run on a StepOne Plus instrument (Applied Biosystems) with Taqman Fast 
Advanced master mix recommended settings. The instrument was set to 40 repeating cycles of 
95°C for 1 second (denaturation) and 20 seconds at 60°C (annealing and extension), with a single 
uracil-N-glycosylase (UNG) incubation period of 2 min at 50°C and polymerase activation of 2 
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min at 95°C prior to cycling. A single pool of RNA from a liver sample harvested in this 
experiment was used to generate the calibrator cDNA used on all plates as a control following the 
2 −∆∆Ct method, and results were expressed as a relative quantity.  
 
Statistical Analysis  
 
Daily means for DMI and milk yield were averaged by week prior to analysis. To 
standardize blood metabolite data, day of blood samples collected 2x / wk or 3x / wk were averaged 
to reference days prior to analysis. All statistical analyses were conducted using SAS (version 9.4, 
SAS Institute Inc., Cary, NC). All data collected over time were analyzed as repeated measures 
ANOVA using the REPEATED statement in the MIXED procedure of SAS (Littell et al., 1996). 
Fixed effects of treatment, time, parity group (2nd vs. 3rd and greater), genotype for all genes, and 
all interactions were included in the model. Cow nested within treatment was the random effect. 
Denominator degrees of freedom were estimated using the Kenward Rogers method. Five 
covariance structures were tested for each model: first-order autoregressive, heterogeneous first-
order autoregressive, compound symmetry, heterogeneous compound symmetry, and 
unstructured; and the covariance structure with the lowest Akaike’s information criterion was used 
(Littell et al., 1996). Residual analysis was performed to examine normality and homogeneity of 
residuals, when non-normality of residual variance was evident, data were log-transformed and 
analysis repeated. In the event of a significant effect of genotype comparison for differences among 
alleles was controlled for multiple comparisons with the Tukey procedure. All data presented are 
least squares means and standard error (SE), except in the case of transformed data where 
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geometric means with back-transformed 95% confidence intervals (CI) are reported. Significance 
was declared at P ≤ 0.05, and trends discussed at 0.05 < P ≤ 0.15.  
Nineteen variables (Table 4) related to liver health, energy balance, and production were 
chosen to test in Pearson correlation in SAS with gene expression of IGF-I, GHR, TNFα, and 
TNFRSF1a. Area under the curve (AUC) was calculated within the first 14 DIM for both NEFA 
and BHB concentrations using the trapezoidal rule as described by Cardoso et al (2011). 
Significance of correlations was declared at P ≤ 0.05. 
Table 4. Variables used in Pearson correlation analysis. 
Variable 
Measured on day 7 and day 14 to correspond with liver biopsies 
Gene Expression- IGF-I  
Gene Expression- Growth Hormone Receptor  
Gene Expression- TNFα  
Gene Expression- TNF Receptor Superfamily Member 1a  
Liver Triglycerides  
Liver Glycogen  
Aspartate Aminotransferase  
Cholesterol  
Glutamate dehydrogenase  
Gamma-glutamyltransferase  
Haptoglobin 
Bilirubin  
Total Protein  
Albumin  
Globulin  
Albumin:Globulin Ratio  
Plasma IGF-I Concentrations  
 
Averaged over wk 1 and wk 2   
Average DMI  
Average milk production 
Calculated Energy Balance  
Average Plasma Glucose Concentrations 
 
Calculated total over 14 days 
Area Under the Curve for blood NEFA 
Area Under the Curve for blood BHBA 
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Results and Discussion  
 
Effect of Dietary Treatment on Hepatic Gene Expression  
 
Hepatic gene expression was measured in relative quantification (RQ) compared to a 
standard control. There were no differences (P>0.15) of dietary treatment on hepatic gene 
expression of IGF-I, GHR, TNFα, or TNFRSF1a (Figure 2). There was, however, a treatment by 
parity effect (P = 0.02), such that cows fed the high fiber diet that were in their third and greater 
lactation had lower hepatic IGF-I expression compared to second lactation cows fed the high fiber 
diet (Figure 3), while cows fed the low fiber diet exhibited no differences due to parity. GHR, 
TNFα, and TNFRSF1a expression did not have a treatment by parity effect. Although there was 
no significant difference in gene expression by treatment group, time did influence hepatic TNFα 
expression (P = 0.002), where d 14 biopsies had significantly higher levels of hepatic TNFα 
expression than d 7 biopsies. 
The lack of an overall effect of treatment was not consistent with my hypothesis that high 
fiber - high starch, early lactation rations would reduce inflammation (marked by lower TNFα and 
TNFRSF1a expression), and increase overall energy balance (marked by an increase in IGF-I and 
GHR expression). The lack of treatment differences observed could have been due to unexpected 
poor forage quality during the trial, which resulted in increased fiber levels for both treatment 
groups; the high fiber treatment diet ended up containing very high fiber levels, while the low fiber 
diet ended up containing adequate fiber levels. Cows fed either diet were likely not at risk for 
SARA due to this increased effective fiber. Instead, the main impact of dietary treatment was that 
cows fed the high fiber diet were limited in intake starting in wk 2 postpartum. This reduction of 
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intake coincided with about 3.6 kg reduction daily milk yield on average during the first four weeks 
of lactation. More research will need to be done to determine if the lack of significant treatment 
groups was due to poor forage quality alone, or if we would have the same results regardless of 
forage quality.  
This limit in intake of cows on the high fiber diet could have contributed to the observed 
treatment by parity effect of hepatic IGF-I expression; older cows generally have higher milk 
production and therefore are more likely to be in greater NEBAL than younger cows (Xu et al., 
2018). This was consistent with data from our study, showing third and greater lactation animals 
to produce 4.3 kg more milk per day on average compared to second lactation animals during the 
first four weeks of lactation. The demands of higher milk production combined with the lack of 
available energy due to decreased intake would leave older cows in a greater energy deficit, marked 
by lower IGF-I expression, than younger cows limited by the same diet.   
The increase in hepatic TNFα expression over time implies that as cows progress further 
into early lactation, they experience more of an inflammatory response. Milk production also 
increased significantly from wk 1 to wk 2 by about 11 kg and 13 kg on average per day in cows 
from the high fiber and low fiber treatment groups respectively. The liver’s increase in TNFα 
expression may have been an inflammatory response to the nutrient demands of a drastic increase 
in production. Our results are somewhat consistent with the Loor et al. (2005) study, which 
reported a significant overall increase in hepatic TNFα expression from day 1 to day 49, but also 
had slight decrease in hepatic TNFα expression from day 1 to day 14. This slight decrease in 
expression could have been due to the small sample size (n = 5) of the study.  
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Figure 2. The hepatic expression of insulin-like growth factor one (IGF-I; P = 0.2772), growth 
hormone receptor (GHR; P = 0.4794), tumor necrosis factor alpha (TNFα; P = 0.521), and TNFα 
receptor superfamily 1a (TNFSRF1a; P = 0.9233) of cows fed diets differing in amount of 
undigested NDF at 240-h of in vitro fermentation (uNDF240) and physically effective NDF 
(peNDF) in the postpartum period. Treatments were low fiber (uNDF240 = 9.5% of DM, peNDF 
= 21% of DM) and high fiber (uNDF240 = 12.2% of DM, peNDF = 23% of DM). Gene expression 
is measured in relative quantification (RQ) compared to a standard control. Day 7 corresponds to 
the liver biopsy taken on d 7 ± 1.1 (mean ± SD), while day 14 corresponds to the liver biopsy taken 
on d 14 ± 1.0 (mean ± SD). IGF-I and TNFα expression are reported as geometric means and back 
transformed 95% confidence intervals. GHR and TNFRSF1a expression are reported as least 
square means and standard error.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Hepatic gene expression of insulin-like growth factor one (IGF-I; P = 0.0257) by parity 
(2nd vs 3rd and greater) for cows fed diets differing in amount of undigested NDF at 240-h of in 
vitro fermentation (uNDF240) and physically effective NDF (peNDF) in the postpartum period. 
Treatments were low fiber (uNDF240 = 9.5% of DM, peNDF = 21% of DM) and high fiber 
(uNDF240 = 12.2% of DM, peNDF = 23% of DM).  Gene expression was measured in relative 
quantification (RQ) compared to a standard control. Data are reported as geometric means and 
back transformed 95% confidence intervals.  
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Effect of Genotype on Hepatic Gene Expression 
 
The effect of Single Nucleotide Polymorphisms (SNP) in IGF-I, GHR, and TNFα on 
hepatic gene expression of IGF-I, GHR, TNFα, and TNFSRF1a was examined. The number of 
cows with each genotype is recorded in Table 5. Because the main purpose of the study was to 
analyze the effect of dietary treatment on hepatic gene expression, we did not genotype the cows 
ahead of time to ensure an equal representation of each genotype. While we still feel like the results 
of the effect of genotype on gene expression are worth sharing, they should be interpreted with 
caution given the small representation of some genotypes.  
There was no effect (P>0.15) of IGF-I genotype on hepatic gene expression of IGF-I, GHR, 
TNFα, or TNFSRF1a (Figure 4A). Cows with GHR SNP AB tended (P<0.15) to have higher 
hepatic IGF-I gene expression compared to cows with GHR SNP AA or BB. GHR genotype AB 
cows also tended (P<0.15) to have a higher GHR expression than cows with genotype AA or BB. 
GHR genotype did not affect (P>0.15) TNFα or TNFSRF1a hepatic gene expression (Figure 4B). 
Cows with TNFα SNP AB tended (P<0.15) to have lower hepatic IGF-I gene expression compared 
to those with TNFα SNP BB. TNFα genotype did not affect (P>0.15) hepatic GHR, TNFα, or 
TNFSRF1a gene expression (Figure 4C). 
The mirrored relationship between IGF-I and GHR expression in regards to GHR genotype 
is not surprising considering the direct effect of GHR concentration on IGF-I expression (Butler 
et al., 2003). The higher hepatic IGF-I expression for GHR genotype AB, however, is inconsistent 
with results from a previous study (Schnider et al., 2013) analyzing associations of GHR 
polymorphisms and the fertility of Holstein cows, where cows with GHR genotype AA had 
significantly higher levels of plasma IGF-I expression. Plasma IGF-I levels are directly influenced 
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by hepatic IGF-I expression (Butler et al., 2003); it would follow that genotype AA cows in this 
study from Schieder et al. (2013) likely had higher hepatic IGF-I expression as well. Considering 
the larger (n = 94) and more evenly distributed sample size in this genotype study compared to our 
own, there is opportunity for additional research analyzing the effect of both GHR genotype and 
IGF-I genotype on hepatic GHR and IGF-I gene expression to gain a more accurate understanding 
of the role genotype plays.  
It is unclear why TNFα genotype in our study did not influence hepatic TNFα expression. 
Limited evidence of the relationship between TNFα and IGF-I expression, however, could explain 
the observed effect of TNFα genotype on hepatic IGF-I expression.  In Briard et al. (2000), an LPS 
challenge induced a rapid increase in plasma concentration of inflammatory cytokines such as 
TNFα, resulting in increased circulating GH concentrations and decreased circulating IGF-I 
concentrations in sheep.  It is possible that TNFα genotype AB could result in an increased 
circulation of TNFα, thus further decreasing hepatic IGF-I expression and ultimately decreasing 
circulating IGF-I when compared to TNFα genotype AA or BB. Again, our results should be 
interpreted with caution given the small and uneven distribution of genotypes.  
 
Table 5. Total number of cows determined with each single nuclear polymorphism genotype for 
insulin-like growth factor one (IGF-I), growth hormone receptor (GHR), and tumor necrosis factor 
alpha (TNFα) 
Allele Type IGF-I Genotype GHR Genotype  TNFα Genotype 
AA 22 16 5 
AB 11 1 13 
BB 2 17 14 
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Figure 4. The effect of IGF-I (A), GHR (B), and TNFα (C) genotype on hepatic expression of 
insulin like growth factor one (IGF-I), growth hormone receptor (GHR), tumor necrosis factor 
alpha (TNFα), and TNFα Receptor Superfamily 1a (TNFRSF1a). IGF-I and TNFα gene expression 
are reported as geometric means and back transformed 95% confidence intervals. GHR and 
TNFRSF1a gene expression are reported as least square means and standard error. P-values are as 
follows: IGF-I expression: IGF-I genotype (P = 0.8496), GHR genotype (P = 0.0623), TNFα 
genotype (P = 0.1068). GHR expression: IGF genotype (P = 0.4595), GHR genotype (P = 0.1167), 
TNFα genotype (P = 0.2011). TNFα expression: IGF-I genotype (P = 0.3367), GHR genotype (P 
= 0.5039), TNFα genotype (P = 0.3629). TNFRSF1a expression: IGF-I genotype (P = 0.776), GHR 
genotype (P = 0.269), TNFα genotype (P = 0.8498). 
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Correlations between Gene Expression and Other Data Collected  
 
Pearson correlation analysis was completed between IGF-I, GHR, TNFα, and TNFRSF1a 
hepatic gene expression and 19 other variables related to health and production; these data are 
shown in tables 6-8).  
Correlations between Gene Expressions 
Hepatic IGF-I expression had a strong, positive correlation with hepatic GHR expression 
on both d 7 and d 14 (Table 6), implying that cows with higher GHR expression also had a higher 
IGF-I expression during the first two weeks of lactation. This is consistent with the understanding 
that the number of hepatic surface GHR has a direct effect on hepatic IGF-I production (Butler et 
al., 2003). Hepatic TNFα expression also had a strong positive correlation with the hepatic 
expression of its receptor, TNFRSF1a, on d 7 and d 14 (Table 6). This relationship was expected, 
given that TNFα signals through TNFRSF1a to activate and induce inflammatory responses 
(Mohankrishnan et al., 2018; Kondo and Sauder 1997). 
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Table 6. Pearson correlations1 between hepatic gene expression of insulin-like growth factor one 
(IGF-I), growth hormone receptor (GHR), tumor necrosis factor alpha (TNFα), and TNFα receptor 
superfamily 1a (TNFRSF1a); d 7 and d 14 correspond to samples taken on liver biopsy day 7 and 
day 14. 
 IGF-I GHR TNFα TNFRSF1a 
 d 7 d 14 d 7 d 14 d 7 d 14 d 7 d 14 
IGF-I d 7 1.000 0.601 
<.0001 
0.534 
0.0004 
0.458 
0.003 
0.044 
0.786 
-0.270 
0.092 
0.037 
0.821 
0.085 
0.602 
IGF-I d 14  1.000 0.297 
0.062 
0.609 
<.0001 
-0.220 
0.173 
-0.259 
0.106 
0.073 
0.654 
0.110 
0.500 
GHR d 7   1.000 0.647 
<.0001 
0.029 
0.857 
-0.233 
0.148 
-0.038 
0.815 
-0.156 
0.337 
GHR d 14    1.000 -0.069 
0.672 
-0.069 
0.672 
-0.012 
0.942 
-0.137 
0.399 
TNFα d 7     1.000 0.417 
0.008 
0.552 
0.0002 
0.205 
0.205 
TNFα d 14      1.000 0.096 
0.556 
0.529 
0.0004 
TNFRSF1a d 7       1.000 0.294 
0.065 
TNFRSF1a d 14        1.000 
 
1Correlation coefficient (r) is the top number, with corresponding P-value beneath.  
 
Correlations with Energy Status, Milk Production, and Metabolism   
Plasma IGF-I: Plasma IGF-I had a strong positive correlation with hepatic IGF-I on d 7 
and d 14 (Table 7) as expected, confirming that hepatic IGF-I gene expression does relate to plasma 
measurements of IGF-I. Plasma IGF-I was also correlated positively with GHR expression on d 7 
and d 14 (Table 7), providing additional support for our understanding of the GH-IGF-I axis. As 
GHR expression in the liver increases, more IGF-I is produced in the liver (Butler et al., 2003) and 
released into circulation.  
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Energy Balance, DMI, and Production: Hepatic expression of IGF-I and GHR on d 7 had 
a positive correlation with wk 1 energy balance, but had no significant correlation with weekly 
average DMI.  There was a negative correlation between hepatic GHR expression on d 7 and milk 
production in wk 1. Hepatic TNFRSF1a expression on d 7 had a strongly negative correlation with 
average milk production in wk 2, and hepatic TNFα expression correlated negatively with average 
blood glucose during wk 2 (Table 7).  
The positive correlation between hepatic IGF-I and GHR expression and energy balance 
without a corresponding positive correlation with DMI suggests that the improvement in energy 
balance from increased IGF-I and GHR expression was not due to increased dietary energy, but 
likely due to reduced body reserve mobilization (Butler et al., 2003), lower milk production (Xu 
et al., 2018), or a likely combination of these factors. This could explain why we observed a 
negative correlation between hepatic GHR expression and milk production during the first week 
of lactation. Hepatic TNFRSF1a expression’s negative correlation with average milk production 
in wk 2 suggests that those individuals with increased inflammation due to an increased 
TNFRSF1a expression (Mohankrishnan et al., 2018; Kondo and Sauder 1997) may have had lower 
milk production. This is consistent with findings that increased inflammation decreases milk 
production (Bionaz et al., 2007; Bradford et al., 2015). It is unclear why hepatic TNFα expression 
did not also have a negative correlation with milk production, but its negative correlation with 
average blood glucose during wk 2 suggests that cows in more severe NEBAL with lower blood 
glucose levels also had a higher inflammatory response.  
Liver Metabolism: Hepatic IGF-I expression on d 7 correlated positively with liver 
glycogen on d 7 and d 14, and hepatic GHR expression on d 7 was correlated positively with 
glycogen on d 14. There was no significant correlations between IGF-I or GHR expression and 
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liver triglycerides, blood NEFA, or blood BHB. There was, however, a positive correlation 
between TNFα on d 14 and liver triglycerides on d 7 (Table 7).  
 Cows release hepatic glycogen stores to increase blood glucose during times of NEBAL 
(McCarthy et al., 2015a). The presence of higher glycogen stores in the liver would indicate cows 
that have a reduced state of NEBAL, as they would not need to release these stores into circulation 
to maintain blood glucose.  This is consistent with our findings that cows with increased hepatic 
IGF-I and GHR expression also had increased liver glycogen stores. Given the known inverse 
relationship between energy balance and liver triglycerides, plasma NEFA, and plasma BHB 
(Strang et al., 1998; Butler et al., 2003, Xiliang et al., 2017), we also expected to see a negative 
correlation between IGF-I expression and these indicators of hepatic metabolism, as well as 
between GHR expression and these indicators. Our results, however, did not show any significant 
correlations between hepatic IGF-I or GHR expression and these variables.  Increased plasma 
NEFA concentration has also been associated with impaired immune function and a 
proinflammatory effect (Gruenberg, 2019), which could explain the observed correlation between 
TNFα and liver triglycerides.  
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Table 7. Pearson correlations1 between insulin-like growth factor one (IGF-I), growth hormone 
receptor (GHR), tumor necrosis factor alpha (TNFα), and TNFα receptor superfamily 1a 
(TNFRSF1a) expression and variables related to energy status, intake, and milk production; d 7 
and d 14 correspond to samples taken on liver biopsy day 7 and day 14. 
 IGF-I GHR TNFα TNFRSF1a 
 d 7 d 14 d 7 d 14 d 7 d 14 d 7 d 14 
Plasma IGF-I d 7 0.806 
<0.0001 
0.499 
0.002 
0.411 
0.012 
0.372 
0.024 
-0.115 
0.498 
-0.211 
0.210 
-0.179 
0.288 
-0.037 
0.828 
Plasma IGF-I d 14 0.585 
0.0001 
0.608 
<0.0001 
0.457 
0.004 
0.492 
0.002 
-0.022 
0.895 
-0.297 
0.074 
0.131 
0.440 
-0.085 
0.618 
EBAL2 wk 1 0.409 
0.013 
0.280 
0.098 
0.324 
0.054 
0.152 
0.375 
0.058 
0.737 
-0.191 
0.264 
0.222 
0.192 
0.166 
0.335 
EBAL wk 2 0.325 
0.065 
0.141 
0.434 
0.213 
0.234 
0.132 
0.464 
0.218 
0.223 
-0.131 
0.466 
0.262 
0.142 
0.225 
0.209 
Avg3 DMI4 wk 1 0.108 
0.512 
0.029 
0.862 
0.096 
0.562 
0.163 
0.321 
-0.031 
0.850 
0.016 
0.924 
-0.042 
0.801 
0.197 
0.231 
Avg DMI wk 2 0.064 
0.700 
0.008 
0.964 
0.140 
0.394 
0.162 
0.324 
-0.176 
0.284 
-0.272 
0.093 
-0.233 
0.153 
-0.007 
0.966 
Avg Milk wk 1 -0.259 
0.111 
-0.195 
0.233 
-0.347 
0.030 
-0.071 
0.667 
0.058 
0.724 
0.280 
0.085 
-0.258 
0.112 
0.065 
0.695 
Avg Milk wk 2 -0.261 
0.109 
-0.104 
0.528 
-0.128 
0.437 
0.101 
0.542 
-0.204 
0.213 
-0.052 
0.751 
-0.528 
0.001 
-0.202 
0.218 
Avg Glucose5 wk 1 0.286 
0.077 
0.143 
0.386 
0.235 
0.150 
0.057 
0.731 
0.107 
0.518 
-0.239 
0.142 
0.105 
0.526 
-0.116 
0.482 
Avg Glucose wk 2 0.300 
0.063 
0.262 
0.108 
0.234 
0.152 
0.185 
0.259 
0.056 
0.736 
-0.334 
0.038 
0.210 
0.200 
-0.030 
0.855 
Liver glycogen d 7 0.514 
0.001 
0.069 
0.674 
0.190 
0.240 
-0.018 
0.914 
-0.002 
0.992 
-0.297 
0.063 
-0.095 
0.561 
0.091 
0.575 
Liver glycogen d 14 0.410 
0.009 
0.297 
0.063 
0.366 
0.020 
0.353 
0.026 
0.056 
0.732 
-0.245 
0.127 
0.032 
0.846 
-0.088 
0.591 
Liver triglycerides  
d 7 
-0.175 
0.280 
0.118 
0.469 
-0.054 
0.741 
0.093 
0.568 
-0.028 
0.865 
0.332 
0.036 
-0.181 
0.264 
0.021 
0.896 
Liver triglycerides 
d 14 
-0.142 
0.381 
0.085 
0.602 
0.073 
0.653 
0.155 
0.340 
-0.084 
0.608 
0.257 
0.109 
-0.198 
0.221 
-0.108 
0.507 
NEFA AUC6 -0.267 
0.100 
-0.038 
0.819 
-0.091 
0.583 
0.008 
0.962 
-0.188 
0.253 
0.159 
0.334 
-0.309 
0.056 
-0.221 
0.176 
BHB AUC7 -0.101 
0.541 
0.026 
0.876 
-0.134 
0.418 
0.016 
0.922 
-0.100 
0.547 
0.063 
0.701 
-0.154 
0.349 
0.029 
0.862 
1Correlation coefficient (r) is the top number, with corresponding P-value beneath.  
2Energy balance, 3Average 4Dry matter intake 5Plasma glucose, 6Area under the curve for plasma non-esterified fatty 
acids (NEFA), 7Area under the curve for plasma beta-hydroxybutyrate (BHB) 
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Correlations with Indicators of Liver Health  
Hepatic Damage Markers: Hepatic IGF-I, GHR, or TNFα expression did not correlate 
with serum levels of the hepatic damage markers aspartate aminotransferase (AST), glutamate 
dehydrogenase (GLDH), and gamma-glutamyl transferase (GGT). There was, however, a negative 
correlation between TNFRSF1a expression and GGT on d 7, as well as TNFRSF1a expression on 
d 14 with AST and GLDH on d 7 (Table 8).  Excessive lipid accumulation in the liver results in 
the overproduction of reactive oxygen species, which alters hepatic cellular integrity and induces 
apoptosis (Schieber and Chandel 2014). Cows with severe oxidative stress have been reported to 
have increased serum levels of hepatic damage markers, including AST, GLDH, GGT (Xiliang et 
al., 2017). With this understanding of the effects of NEBAL on hepatic damage markers, it is 
unusual that we did not find negative correlations between IGF-I and GHR expression and these 
markers. The negative correlations between TNFRSF1a expression and these hepatic damage 
markers further complicate our previous understanding of the relationship between inflammation 
and oxidative stress; one of the primary responsibilities of TNFα is to induce apoptosis (Idriss and 
Naismith, 2000), so it would be expected that cows with greater oxidative stress and higher levels 
of circulating hepatic damage markers would also have higher hepatic TNFα and TNFRSF1a 
expression.  
The Acute Phase Response: Hepatic expression of IGF-I was correlated positively with 
plasma concentrations of both albumin and cholesterol. Hepatic expression of IGF-I on d 7 and 
GHR on d 14 were correlated negatively with plasma globulin and positively with albumin to 
globulin ratio in plasma. Hepatic TNFRSF1a expression showed a negative correlation with 
plasma albumin and a positive correlation with plasma haptoglobin. Plasma concentrations of 
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bilirubin showed a few significant correlations with our genes of interest; hepatic TNFRSF1a 
expression had a negative correlation with bilirubin on d 14, and hepatic IGF-I expression had a 
negative correlation with bilirubin on d 7. There was no significant correlation between total 
protein and hepatic expression of our genes of interest (Table 8).  
During the acute phase response, the activity of the liver is diverted from the synthesis of 
usual proteins that are considered negative APP, to the synthesis of undesirable positive APP 
(Bertoni and Trevisi, 2013). This makes liver protein synthesis a valuable indicator to assess liver 
health during the transition period. Albumin is a negative APP that is frequently used to determine 
inflammatory response; in nearly all species, albumin decreases in blood concentration during the 
acute phase reaction (Kaneko, 1997, from Cray 2009). Precursors to cholesterol are also 
considered negative APP (Bertoni and Trevesi, 2013), which means that cholesterol should also 
decrease during the acute phase reaction. The positive correlation of hepatic IGF-I expression and 
plasma concentrations of both negative APP albumin and cholesterol suggests that cows in greater 
energy balance have improved liver health. This would be expected, considering that the cow must 
depend almost entirely on hepatic gluconeogenesis to meet tissue glucose requirements (Elliot, 
1980; Brockman, 1993; Bell and Bauman, 1997), and a liver in better metabolic condition would 
be more suited to complete this task. The negative correlation between plasma albumin, a negative 
APP, and TNFRSF1a expression suggests that cows with a greater acute phase inflammatory 
response have a higher expression of TNFRSF1a. The positive correlation between plasma 
haptoglobin and hepatic TNFRSF1a expression further supports our understanding of the positive 
relationship between inflammation and positive APP.  
 Bilirubin behaves similarly to haptoglobin during the acute phase reaction; while bilirubin 
is not an APP, enzymes that clear bilirubin behave in a pattern of negative APP. During the acute 
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phase response, the production of these enzymes are lowered. This leaves a higher concentration 
of bilirubin in circulation, making increased plasma bilirubin levels a marker of decreased liver 
health (Bertoni and Trevesi, 2013). The negative correlation between hepatic IGF-I expression and 
plasma bilirubin suggests that cows in greater NEBAL also have decreased liver health and 
function. The negative correlation between hepatic TNFRSF1a expression and bilirubin was 
unexpected given our understanding of increased bilirubin during the acute phase response 
(Bertoni and Trevesi, 2013).  
Globulins are considered to be all serum proteins that are not albumin. Therefore, globulin 
= total protein – albumin (Cornell Vet Med., 2013). The albumin to globulin to ratio is 
consequently a helpful indicator of overall liver health and inflammatory status. A higher albumin 
to globulin ratio implies increased liver health, while a lower ratio implies decreased serum 
albumin and therefore decreased liver health during the acute phase reaction. The negative 
correlation between plasma globulin and hepatic expression of IGF-I and GHR, as well as the 
positive correlations between albumin to globulin ratio and hepatic expression of IGF-I and GHR, 
suggests that cows in more positive energy balance also have improved liver health. We would 
expect hepatic TNFα expression to negatively correlate with the albumin to globulin ratio 
considering a higher ratio means a reduced inflammatory status (Bertoni and Trevesi, 2013; 
eClinpath Cornell Vet Med, 2013), but we did not find such correlations.  
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Table 8. Pearson correlations1 between insulin-like growth factor one (IGF-I), growth hormone 
receptor (GHR), tumor necrosis factor alpha (TNFα), and TNFα receptor superfamily 1a 
(TNFRSF1a) expression and plasma variables related to liver health; d 7 and d 14 correspond to 
samples taken on liver biopsy day 7 and day 14. 
 IGF-I GHR TNFα TNFRSF1a 
 d 7 d 14 d 7 d 14 d 7 d 14 d 7 d 14 
AST2 d 7 -0.090 
0.579 
-0.059 
0.718 
-0.002 
0.988 
0.031 
0.850 
-0.173 
0.285 
-0.131 
0.419 
-0.273 
0.089 
-0.354 
0.025 
AST d 14 -0.068 
0.677 
-0.040 
0.808 
-0.020 
0.904 
-0.013 
0.937 
-0.234 
0.146 
-0.171 
0.290 
-0.210 
0.192 
-0.296 
0.064 
Cholesterol d 7 0.431 
0.006 
0.356 
0.024 
0.199 
0.217 
0.171 
0.293 
-0.110 
0.497 
-0.033 
0.842 
0.006 
0.968 
0.070 
0.668 
Cholesterol d 14 0.312 
0.050 
0.243 
0.131 
0.061 
0.710 
0.117 
0.470 
-0.184 
0.256 
-0.081 
0.620 
0.063 
0.700 
-0.0003 
0.999 
GLDH3 d 7 -0.036 
0.826 
0.133 
0.413 
0.173 
0.286 
0.254 
0.113 
-0.218 
0.176 
-0.238 
0.139 
-0.254 
0.114 
-0.347 
0.028 
GLDH d 14 -0.110 
0.501 
-0.135 
0.408 
-0.071 
0.665 
-0.180 
0.268 
-0.175 
0.281 
-0.187 
0.247 
-0.270 
0.092 
-0.230 
0.154 
GGT4 d 7 0.285 
0.075 
0.084 
0.606 
0.122 
0.452 
0.055 
0.735 
-0.199 
0.218 
-0.289 
0.070 
-0.360 
0.023 
-0.227 
0.159 
GGT d 14 0.101 
0.534 
0.031 
0.852 
-0.057 
0.726 
-0.179 
0.268 
-0.255 
0.112 
-0.256 
0.110 
-0.274 
0.088 
-0.134 
0.410 
Haptoglobin d 7 -0.273 
0.088 
0.047 
0.774 
-0.035 
0.832 
-0.136 
0.404 
-0.011 
0.946 
0.0001 
0.999 
0.326 
0.040 
0.007 
0.965 
Haptoglobin d 14 -0.184 
0.255 
-0.047 
0.773 
-0.039 
0.812 
-0.234 
0.146 
0.069 
0.673 
0.140 
0.391 
0.220 
0.172 
0.373 
0.018 
Bilirubin d 7 -0.357 
0.024 
-0.166 
0.306 
-0.113 
0.487 
-0.015 
0.929 
0.258 
0.108 
0.400 
0.011 
-0.031 
0.851 
-0.186 
0.251 
Bilirubin d 14 -0.160 
0.323 
-0.243 
0.132 
-0.098 
0.548 
-0.195 
0.228 
-0.046 
0.777 
0.070 
0.670 
-0.383 
0.015 
-0.257 
0.110 
Total Protein d 7 -0.182 
0.261 
-0.273 
0.089 
-0.083 
0.612 
-0.282 
0.077 
-0.069 
0.674 
0.138 
0.395 
-0.254 
0.114 
-0.047 
0.771 
Total Protein d 14 -0.249 
0.121 
-0.151 
0.352 
-0.065 
0.691 
-0.224 
0.165 
-0.067 
0.680 
0.043 
0.794 
0.209 
0.196 
0.088 
0.591 
Albumin d 7 0.451 
0.004 
-0.017 
0.918 
0.226 
0.161 
0.180 
0.267 
0.081 
0.621 
-0.155 
0.340 
-0.210 
0.193 
-0.321 
0.044 
Albumin d 14 0.223 
0.167 
0.026 
0.875 
0.150 
0.356 
0.231 
0.152 
-0.109 
0.502 
-0.159 
0.326 
0.032 
0.846 
-0.207 
0.199 
Globulin d 7 -0.316 
0.047 
-0.241 
0.135 
-0.151 
0.353 
-0.315 
0.047 
-0.089 
0.585 
0.177 
0.275 
-0.158 
0.330 
0.065 
0.690 
Globulin d 14 -0.317 
0.046 
-0.163 
0.315 
-0.107 
0.510 
-0.293 
0.066 
-0.040 
0.805 
0.087 
0.594 
0.207 
0.200 
0.146 
0.368 
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Albumin to 
Globulin ratio d 7 
0.379 
0.016 
0.176 
0.279 
0.199 
0.220 
0.309 
0.053 
0.141 
0.385 
-0.162 
0.317 
0.123 
0.450 
-0.120 
0.462 
Albumin to 
Globulin ratio d 14 
0.436 
0.005 
0.224 
0.166 
0.223 
0.167 
0.414 
0.008 
-0.002 
0.989 
-0.126 
0.437 
-0.096 
0.555 
-0.156 
0.336 
1Correlation coefficient (r) is the top number, with corresponding P-value beneath.  
2Aspartate aminotransferase, 3Glutamate dehydrogenase, 4Gamma-glutamyltransferase, 
 
Conclusions 
 
While we did not observe a difference in hepatic gene expression of IGF-I, GHR, TNFα, 
or TNFRSF1a based on varying dietary fiber treatments alone, there was a treatment by parity 
effect, where cows in their third lactation or greater on the high fiber diet had lower IGF-I 
expression than cows in their second lactation on the high fiber diet. This might indicate that older, 
higher producing cows are more prone to the impacts of dietary restrictions and NEBAL.  
There was an observed effect of genotype on gene expression, where the GHR genotype 
AB tended to have higher IGF-I and GHR expression, and the TNFα genotype AB tended to have 
lower IGF-I expression, though these results should be interpreted with caution given low sample 
numbers for certain alleles. Given these findings with a small and unevenly distributed sample 
size, the effect of IGF-I, GHR, and TNFα genotype on hepatic gene expression with a larger 
population of cattle is an area of future research.  
Finally, hepatic expression of IGF-I and GHR generally correlated positively with 
variables related to improved energy balance and liver health, while hepatic expression of TNFα 
and TNFRSF1a correlated positively with markers associated with decreased energy balance and 
liver health. This further supports the concept that NEBAL, metabolism, and inflammation are all 
interrelated.  
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